Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP470696.RAtV4kEYiGPe37jGWEP2x0nl-Ou4Bm7Sv6gY6zSFQ3rM0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP470696.RAtV4kEYiGPe37jGWEP2x0nl-Ou4Bm7Sv6gY6zSFQ3rM0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP470696.RAtV4kEYiGPe37jGWEP2x0nl-Ou4Bm7Sv6gY6zSFQ3rM0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP470696.RAtV4kEYiGPe37jGWEP2x0nl-Ou4Bm7Sv6gY6zSFQ3rM0130_provenance.
- NP470696.RAtV4kEYiGPe37jGWEP2x0nl-Ou4Bm7Sv6gY6zSFQ3rM0130_assertion description "[Furthermore, our data show that pharmacological concentrations of celecoxib may interfere with the proapoptotic action of R(+)-MA and anandamide, suggesting that cotreatment with COX-2 inhibitors could diminish glioma regression induced by these compounds.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470696.RAtV4kEYiGPe37jGWEP2x0nl-Ou4Bm7Sv6gY6zSFQ3rM0130_provenance.
- NP470696.RAtV4kEYiGPe37jGWEP2x0nl-Ou4Bm7Sv6gY6zSFQ3rM0130_assertion evidence source_evidence_literature NP470696.RAtV4kEYiGPe37jGWEP2x0nl-Ou4Bm7Sv6gY6zSFQ3rM0130_provenance.
- NP470696.RAtV4kEYiGPe37jGWEP2x0nl-Ou4Bm7Sv6gY6zSFQ3rM0130_assertion SIO_000772 15361550 NP470696.RAtV4kEYiGPe37jGWEP2x0nl-Ou4Bm7Sv6gY6zSFQ3rM0130_provenance.
- NP470696.RAtV4kEYiGPe37jGWEP2x0nl-Ou4Bm7Sv6gY6zSFQ3rM0130_assertion wasDerivedFrom befree-20140225 NP470696.RAtV4kEYiGPe37jGWEP2x0nl-Ou4Bm7Sv6gY6zSFQ3rM0130_provenance.
- NP470696.RAtV4kEYiGPe37jGWEP2x0nl-Ou4Bm7Sv6gY6zSFQ3rM0130_assertion wasGeneratedBy ECO_0000203 NP470696.RAtV4kEYiGPe37jGWEP2x0nl-Ou4Bm7Sv6gY6zSFQ3rM0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP470696.RAtV4kEYiGPe37jGWEP2x0nl-Ou4Bm7Sv6gY6zSFQ3rM0130_provenance.